Michael Wayne Kalb's Net Worth
$11.5 Million
Who is Michael Wayne Kalb?
Michael Wayne Kalb has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, IMPEL PHARMACEUTICALS INC, CinCor Pharma, Inc., and CATALYST PHARMACEUTICALS, INC..
SEC CIK
Michael Wayne Kalb's CIK is 0001678248
Past Insider Trading and Trends
2021 was Michael Wayne Kalb's most active year for acquiring shares with 33 total transactions. Michael Wayne Kalb's most active month to acquire stocks was the month of January. 2021 was Michael Wayne Kalb's most active year for disposing of shares, totalling 43 transactions. Michael Wayne Kalb's most active month to dispose stocks was the month of January. 2018 saw Michael Wayne Kalb paying a total of $773,100.00 for 374,000 shares, this is the most they've acquired in one year. In 2019 Michael Wayne Kalb cashed out on 931,935 shares for a total of $8,671,763.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
SVP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.14% | 865 |
$1.33 | -$62,379.66 | 621.98K |
Jul 29 - Aug 1
| |||
Form 4
| +4.21% | 10.12K |
$3.27 | -$20,316.51 | 250.75K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +3.18% | 7.42K |
$3.36 | -$17,865.12 | 240.63K |
Jan 31
| |||
Form 4
| +10.62% | 22.39K |
$3.35 | -$85,019.65 | 233.21K |
Dec 31
| |||
Form 4
| +1.51% | 3.1K |
$5.54 | -$16,680.94 | 208.11K |
Aug 31
| |||
Form 4
|
—
|
0
|
$3.80 | -$348,440.00 | 205.01K |
Scheduled
|
Aug 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
| +1.53% | 3.1K |
$4.14 | -$12,465.54 | 205.01K |
Jul 30
| |||
Form 4
| +1.56% | 3.1K |
$4.48 | -$13,489.28 | 201.91K |
Jun 30
| |||
Form 4
| +1.59% | 3.12K |
$4.54 | -$13,597.30 | 198.82K |
May 28
| |||
Form 4
| +1.64% | 3.12K |
$5.24 | -$15,693.80 | 193.15K |
Apr 30
| |||
Form 4
| +1.67% | 3.12K |
$6.37 | -$19,078.15 | 190.04K |
Mar 31
| |||
Form 4
| +43.44% | 56.61K |
$7.19 | -$391,294.20 | 186.92K |
Feb 25 - Feb 26
| |||
Form 4
| +25.97% | 26.86K |
$7.50 | -$111,960.00 | 130.31K |
Jan 29
| |||
Form 4
| +1.53% | 1.56K |
$5.23 | -$7,834.54 | 103.45K |
Dec 31 - Jan 4
| |||
Form 4
| +1.55% | 1.56K |
$4.60 | -$6,890.80 | 101.89K |
Nov 30
| |||
Form 4
| +1.61% | 1.56K |
$4.86 | -$7,280.28 | 98.47K |
Oct 30
| |||
Form 4
| +3.26% | 3.06K |
—
|
—
| 96.91K |
Sep 30
| |||
Form 4
| +1.69% | 1.56K |
$7.36 | -$11,010.56 | 93.86K |
Aug 31
| |||
Form 4
| +1.71% | 1.56K |
$6.59 | -$9,871.82 | 92.3K |
Jul 31
| |||
Form 4
| +1.75% | 1.56K |
$6.72 | -$10,053.12 | 90.74K |
Jun 30
| |||
Form 4
| +1.78% | 1.56K |
$6.86 | -$10,276.28 | 89.19K |
May 29
| |||
Form 4
| +1.82% | 1.56K |
$8.26 | -$12,373.48 | 87.04K |
Apr 30
| |||
Form 4
| +1.86% | 1.56K |
$13.58 | -$20,342.84 | 85.48K |
Mar 31
| |||
Form 4
| +1.89% | 1.56K |
$14.67 | -$21,975.66 | 83.93K |
Feb 28 - Mar 2
| |||
Form 4
| +47.45% | 26.51K |
$17.58 | -$447,235.20 | 82.37K |
Feb 25
| |||
Form 4
| +159.19% | 34.31K |
$19.04 | -$636,412.00 | 55.86K |
Jan 31 - Feb 3
| |||
Form 4
|
—
|
0
|
$12.78 | -$529,261.53 | 21.55K |
Scheduled
|
Dec 16
| ||
Form 4
|
—
|
0
|
$10.93 | -$873,770.00 | 20.84K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$12.46 | -$1,925,748.34 | 20.55K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$10.96 | -$801,000.00 | 20.55K |
Scheduled
|
Feb 22
| ||
Form 4
| -54.88% | -25.00K |
$17.58 | -$439,525.00 | 20.55K |
Scheduled
|
Feb 15
| ||
Form 4
| +160.50% | 28.07K |
$16.94 | -$456,278.90 | 45.55K |
Jan 31 - Feb 1
| |||
Form 4
|
—
|
0
|
$8.73 | -$2,613,080.00 | 17.49K |
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
$6.31 | -$1,234,250.82 | 15K |
Scheduled
|
Sep 24
| ||
Form 4
|
∞
| 15K |
$3.83 | -$53,635.32 | 15K |
Jan 31 - Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL PHARMACEUTICALS INC (IMPL) No price found
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CinCor Pharma, Inc. No price found
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -202.44K |
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +695.84% | 177K |
—
|
—
| 202.44K |
Jan 26
| |||
Form 4
|
∞
| 25.44K |
—
|
—
| 25.44K |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CATALYST PHARMACEUTICALS, INC. (CPRX) Snapshot price: $19.2514
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||